Summary
Further key aspects of the report:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Osteoarthritis Pain Drugs market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Osteoarthritis Pain Drugs market segmented into
Oral
Injection
External
Based on the end-use, the global Osteoarthritis Pain Drugs market classified into
Hospitals
Clinics
Others
Based on geography, the global Osteoarthritis Pain Drugs market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Abbott Laboratories
Johnson & Johnson
Novartis International
Pfizer
Abiogen Pharma
Afferent Pharmaceuticals
Astellas Pharma
BioDelivery Sciences International
Crystal Genomics
Cytori Therapeutics
Daiichi Sankyo
Eli Lilly
Endo Pharmaceuticals Holdings
Horizon Pharma
ICeutica
Iroko Pharmaceuticals
Merck
Nuvo Research
Regeneron Pharmaceuticals
Sanofi
SantoSolve
Techfields Pharma
Winston Pharmaceuticals
Yooyoung Pharmaceutical
Zynerba Pharmaceuticals
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL OSTEOARTHRITIS PAIN DRUGS INDUSTRY
2.1 Summary about Osteoarthritis Pain Drugs Industry
2.2 Osteoarthritis Pain Drugs Market Trends
2.2.1 Osteoarthritis Pain Drugs Production & Consumption Trends
2.2.2 Osteoarthritis Pain Drugs Demand Structure Trends
2.3 Osteoarthritis Pain Drugs Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Oral
4.2.2 Injection
4.2.3 External
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Clinics
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Oral
5.2.2 Injection
5.2.3 External
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Clinics
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Oral
6.2.2 Injection
6.2.3 External
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Clinics
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Oral
7.2.2 Injection
7.2.3 External
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Clinics
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Oral
8.2.2 Injection
8.2.3 External
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Clinics
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Oral
9.2.2 Injection
9.2.3 External
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Clinics
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Abbott Laboratories
10.1.2 Johnson & Johnson
10.1.3 Novartis International
10.1.4 Pfizer
10.1.5 Abiogen Pharma
10.1.6 Afferent Pharmaceuticals
10.1.7 Astellas Pharma
10.1.8 BioDelivery Sciences International
10.1.9 Crystal Genomics
10.1.10 Cytori Therapeutics
10.1.11 Daiichi Sankyo
10.1.12 Eli Lilly
10.1.13 Endo Pharmaceuticals Holdings
10.1.14 Horizon Pharma
10.1.15 ICeutica
10.1.16 Iroko Pharmaceuticals
10.1.17 Merck
10.1.18 Nuvo Research
10.1.19 Regeneron Pharmaceuticals
10.1.20 Sanofi
10.1.21 SantoSolve
10.1.22 Techfields Pharma
10.1.23 Winston Pharmaceuticals
10.1.24 Yooyoung Pharmaceutical
10.1.25 Zynerba Pharmaceuticals
10.2 Osteoarthritis Pain Drugs Sales Date of Major Players (2017-2020e)
10.2.1 Abbott Laboratories
10.2.2 Johnson & Johnson
10.2.3 Novartis International
10.2.4 Pfizer
10.2.5 Abiogen Pharma
10.2.6 Afferent Pharmaceuticals
10.2.7 Astellas Pharma
10.2.8 BioDelivery Sciences International
10.2.9 Crystal Genomics
10.2.10 Cytori Therapeutics
10.2.11 Daiichi Sankyo
10.2.12 Eli Lilly
10.2.13 Endo Pharmaceuticals Holdings
10.2.14 Horizon Pharma
10.2.15 ICeutica
10.2.16 Iroko Pharmaceuticals
10.2.17 Merck
10.2.18 Nuvo Research
10.2.19 Regeneron Pharmaceuticals
10.2.20 Sanofi
10.2.21 SantoSolve
10.2.22 Techfields Pharma
10.2.23 Winston Pharmaceuticals
10.2.24 Yooyoung Pharmaceutical
10.2.25 Zynerba Pharmaceuticals
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
Table Osteoarthritis Pain Drugs Product Type Overview
Table Osteoarthritis Pain Drugs Product Type Market Share List
Table Osteoarthritis Pain Drugs Product Type of Major Players
Table Brief Introduction of Abbott Laboratories
Table Brief Introduction of Johnson & Johnson
Table Brief Introduction of Novartis International
Table Brief Introduction of Pfizer
Table Brief Introduction of Abiogen Pharma
Table Brief Introduction of Afferent Pharmaceuticals
Table Brief Introduction of Astellas Pharma
Table Brief Introduction of BioDelivery Sciences International
Table Brief Introduction of Crystal Genomics
Table Brief Introduction of Cytori Therapeutics
Table Brief Introduction of Daiichi Sankyo
Table Brief Introduction of Eli Lilly
Table Brief Introduction of Endo Pharmaceuticals Holdings
Table Brief Introduction of Horizon Pharma
Table Brief Introduction of ICeutica
Table Brief Introduction of Iroko Pharmaceuticals
Table Brief Introduction of Merck
Table Brief Introduction of Nuvo Research
Table Brief Introduction of Regeneron Pharmaceuticals
Table Brief Introduction of Sanofi
Table Brief Introduction of SantoSolve
Table Brief Introduction of Techfields Pharma
Table Brief Introduction of Winston Pharmaceuticals
Table Brief Introduction of Yooyoung Pharmaceutical
Table Brief Introduction of Zynerba Pharmaceuticals
Table Products & Services of Abbott Laboratories
Table Products & Services of Johnson & Johnson
Table Products & Services of Novartis International
Table Products & Services of Pfizer
Table Products & Services of Abiogen Pharma
Table Products & Services of Afferent Pharmaceuticals
Table Products & Services of Astellas Pharma
Table Products & Services of BioDelivery Sciences International
Table Products & Services of Crystal Genomics
Table Products & Services of Cytori Therapeutics
Table Products & Services of Daiichi Sankyo
Table Products & Services of Eli Lilly
Table Products & Services of Endo Pharmaceuticals Holdings
Table Products & Services of Horizon Pharma
Table Products & Services of ICeutica
Table Products & Services of Iroko Pharmaceuticals
Table Products & Services of Merck
Table Products & Services of Nuvo Research
Table Products & Services of Regeneron Pharmaceuticals
Table Products & Services of Sanofi
Table Products & Services of SantoSolve
Table Products & Services of Techfields Pharma
Table Products & Services of Winston Pharmaceuticals
Table Products & Services of Yooyoung Pharmaceutical
Table Products & Services of Zynerba Pharmaceuticals
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Osteoarthritis Pain Drugs Market Forecast (Million USD) by Region 2021f-2026f
Table Global Osteoarthritis Pain Drugs Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Osteoarthritis Pain Drugs Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Osteoarthritis Pain Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Osteoarthritis Pain Drugs Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Osteoarthritis Pain Drugs Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Osteoarthritis Pain Drugs Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Osteoarthritis Pain Drugs Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Osteoarthritis Pain Drugs Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Osteoarthritis Pain Drugs Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Osteoarthritis Pain Drugs Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure External Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure External Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure External Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure External Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure External Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure External Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Osteoarthritis Pain Drugs Sales Revenue (Million USD) of Abbott Laboratories 2017-2020e
Figure Osteoarthritis Pain Drugs Sales Revenue (Million USD) of Johnson & Johnson 2017-2020e
Figure Osteoarthritis Pain Drugs Sales Revenue (Million USD) of Novartis International 2017-2020e
Figure Osteoarthritis Pain Drugs Sales Revenue (Million USD) of Pfizer 2017-2020e
Figure Osteoarthritis Pain Drugs Sales Revenue (Million USD) of Abiogen Pharma 2017-2020e
Figure Osteoarthritis Pain Drugs Sales Revenue (Million USD) of Afferent Pharmaceuticals 2017-2020e
Figure Osteoarthritis Pain Drugs Sales Revenue (Million USD) of Astellas Pharma 2017-2020e
Figure Osteoarthritis Pain Drugs Sales Revenue (Million USD) of BioDelivery Sciences International 2017-2020e
Figure Osteoarthritis Pain Drugs Sales Revenue (Million USD) of Crystal Genomics 2017-2020e
Figure Osteoarthritis Pain Drugs Sales Revenue (Million USD) of Cytori Therapeutics 2017-2020e
Figure Osteoarthritis Pain Drugs Sales Revenue (Million USD) of Daiichi Sankyo 2017-2020e
Figure Osteoarthritis Pain Drugs Sales Revenue (Million USD) of Eli Lilly 2017-2020e
Figure Osteoarthritis Pain Drugs Sales Revenue (Million USD) of Endo Pharmaceuticals Holdings 2017-2020e
Figure Osteoarthritis Pain Drugs Sales Revenue (Million USD) of Horizon Pharma 2017-2020e
Figure Osteoarthritis Pain Drugs Sales Revenue (Million USD) of ICeutica 2017-2020e
Figure Osteoarthritis Pain Drugs Sales Revenue (Million USD) of Iroko Pharmaceuticals 2017-2020e
Figure Osteoarthritis Pain Drugs Sales Revenue (Million USD) of Merck 2017-2020e
Figure Sales Revenue (Million USD) of Nuvo Research 2017-2020e
Figure Sales Revenue (Million USD) of Regeneron Pharmaceuticals 2017-2020e
Figure Sales Revenue (Million USD) of Sanofi 2017-2020e
Figure Sales Revenue (Million USD) of SantoSolve 2017-2020e
Figure Sales Revenue (Million USD) of Techfields Pharma 2017-2020e
Figure Sales Revenue (Million USD) of Winston Pharmaceuticals 2017-2020e
Figure Sales Revenue (Million USD) of Yooyoung Pharmaceutical 2017-2020e
Figure Sales Revenue (Million USD) of Zynerba Pharmaceuticals 2017-2020e